The Drug Controller General of India (DCGI) has sought clarification from pharma majors Dr Reddy’s Laboratories and Mumbai-based Piramal Healthcare for allegedly sponsoring doctors for conferences.
According to Ketan D Desai, president, Medical Council of India (MCI), the two companies have not provided the list of doctors sponsored by them.
Sources in DCGI confirmed having issued letters to the companies seeking information on doctors allegedly sponsored by them.
“It is against MCI rules. No doctor should accept any kind of favours and gifts from pharma companies. The companies did not respond properly when we sought the names of doctors and their registration numbers. We have no option but to approach DCGI to get the details from the companies,” Desai said.
He said Dr Reddy’s sponsored a conference recently in Hyderabad and allegedly bore all the expenses of the doctors who attended it. Piramal Healthcare allegedly sponsored a group of doctors to attend a conference on diabetes in Turkey.
When contacted, G V Prasad, vice-chairman and CEO, Dr Reddy’s, downplayed the issue, saying they received a letter from DCGI seeking some information which they had provided.
Taking serious note of the issue, Desai said if the companies continued to give them vague replies, they would take up the issue with the health ministry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
